Design Template
17-18 November 2014 | Marriott Grosvenor
Supporting Partners

Founded over 25 years ago at the infancy of biotechnology, the UK BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience.  Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector.  The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media.  Our goal is to secure the UK’s position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people’s lives.

BIA UK Bioscience Forum will take place on Tuesday 7 October in London. For more information please visit: 

Current Partnering is the leading publisher of deal term reports within the life sciences. Designed to translate research into commercial success, Current Partnering disseminates the latest partnering activity trends across the life sciences.
Current Partnering report titles cover all aspects of partnering best practice and deal terms, providing users with the information and insight required to optimise their partnering activities.
Current Agreements is a premium subscription database providing comprehensive business information and intelligence, with access to thousands of contract documents and giving coverage of all deals and alliances across the Life Sciences sector dating back to 2000.

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world. The pharmaceutical industry contributes many benefits to Europe and its citizens: Better quality healthcare and treatment choices;
Value solutions that meet national healthcare and social security budgets; Investment in innovation in Europe, bringing highly skilled employment and contributing economic benefits.

EFPIA has a number of events coming up over October, (15 October - EFPIA Public Conference, Brussels, 16 - 17 October - Healthcare Collaboration Summit, Brussels)

To find out more please click here >>

European Pharmaceutical Review is the leading publication for information on technologies in drug discovery and manufacturing. Published bi-monthly, every issue offers a high level of technical and business contributions from the world’s leading pharmaceutical companies and academic institutions, coupled with a variety of exciting new features including interviews, updates and profiles.

MedTech Europe is an Alliance of European medical technology industry associations. The Alliance was founded in October 2012 and currently has two members being EDMA, representing the European in vitro diagnostic industry, and Eucomed, representing the European medical devices industry. Other European medical technology associations are welcome to join the Alliance. MedTech Europe, EDMA and Eucomed remain separate entities but are led by one joint Chief Executive and work closely together on common policy interest areas.

The PharmaTimes portfolio includes PharmaTimes Magazine for independent reporting; PharmaTimes digital at; our daily World e-news service delivered by email; PharmaTimes Directors' Club, where thought-leaders meet to discuss the issues of the day; and a unique series of competitions including marketing, clinical, sales and business leadership that help industry professionals develop and hone their skills.